Sub-Chronic Effect Of Co-Administration Of Methformine And Amilodipine On Some Haematological Indices In Experimental Animal (Wistar Rats)

Sub-Chronic Effect Of Co-Administration Of Methformine And Amilodipine On Some Haematological Indices In Experimental Animal (Wistar Rats)
Abstract
Metformin, which belongs to the biguanide class, is one of the most generally used oral hypoglycemic agents. It has been used for more than 50 years and was approved by the US Food and Drug Administration (FDA) in 1994 (American Diabetes Association, 2009) whereas Amlodipine is a long acting dihydropyridine calcium channel blocker, which is used in the treatment of angina to lower the BP (Blood pressure).the aim is to know the effect of co-administration of this two drugs in Wistar rats. To assess the MCV,MCH,MCHC level of experimental animal and that of control group after combined administration with amlodipine and metformin. Animals were randomly grouped into Two (A and B) groups, each groups contains eight (8) animals. Group A was administered normal saline; Group B was administered combined administration with amlodipine (0.00264mg/ml/132g) and metformin(0.0438mg/ml/132g) once daily for 30days after 2 weeks of acclimatization. Each group of rats was allowed to have free access to watered libitum and standard rat chow (SRC) throughout the experimental period. *
Blood was collected from the Jugular vein at the end of the experiment to determine the full blood count of each animal. There was a significant reduction (p≤0.05) in hemoglobin level, RBC, PCV and increase in WBC and decrease in PLT count, and with increase in MCV, MCH with no difference in MCHC after co-administration of Metformin and Amlodipine in Wistar Rat as compared to control. These findings suggests that Co-administration of Metformin and Amlodipine causes decrease in red cell dependent parameters gradually leading to anaemia with long term usage thus regarded as a hepatotoxicity agent to the blood profile.
Key words: Metformin, Amlodipine, haematological parameters, Wistar Rats.
Table of Content
- Title page
- Declaration
- Certification
- Dedication
- Acknowledgement
- Table of content
- List of table
- List of figures
- Abstract
Chapter One
- 1.0 Introduction
- 1.1 Background of study
- 1.2 Statement of Problems
- 1.3 Justifications
- 1.4 Aims
- 1.5 Research Objectives
- 1.6 Research Hypothesis
- 1.7 Significance of research
Chapter Two
- 2.0 Literature review
- 2.1 Metformin
- 2.1.1 Mechanism of metformin
- 2.1.2 Pharmacological properties of metformin
- 2.1.3 Side effects and contra-indications of metformin
- 2.1.4 Therapeutic application of metformin
- 2.2 Vitamin B12: biochemistry, deficiency and anaemia
- 2.3 Relationship between metformin and vitamin B12
- 2.4 Metformin and haemolytic anaemia
- 2.5 Diagnosis of anaemia
- 2.6 Efficacy of Metformin
- 2.7 Amlodipine
- 2.7.1 Chemistry
- 2.7.2 Mechanism of action
- 2.7.3 Side effects
- 2.7.4 Pharmacokinetics
- 2.8 Angiotensin Converting Enzyme Inhibitors
- 2.9 Reference range of haematological parameters of rats
- 2.10 Comparative haematology of rat and human
Chapter Three
- 3.1 Study Design
- 3.2 Preparation of animals
- 3.3 Sample size determination
- 3.4 Reagent Kits/Drug Preparation and Dosage
- 3.5 Dosage
- 3.6 Sample collection
- 3.7 Measurement of variables
- 3.8 Ethical consideration 46
- 3.9 Statistical analysis
Chapter Four
- 4.1 Result
- 4.2 Differential white blood cell counts in controls and tests groups
Chapter Five
- 5.0 Discussion
- 5.1 Conclusion
- 5.2 Recommendation
- References
- Appendix I
- Appendix II
List of Tables
- Table 1: Haematological parameters in control, Co-administration of Metformin and Amlodipine treated 39
List of Figures
- Figure 1: Shows mechanism of action of metformin
- Figure 2: Shows Pie chat representation of Packed cell volumeof control, Co-administration of metformin and amlodipine treated Wistar Rats
- Figure 3: Shows Histogram representation of Hemoglobin and red blood cell count of control, Co-administration of metformin and amlodipine treated Wistar Rats
- Figure 4: Shows Histogram representation of red cell indicies of control, Co-administration of metformin and amlodipine treated Wistar Rats
- Figure 5: Shows Histogram representation of platelet and white blood cell count of control, Co-administration of metformin and amlodipine treated Wistar Rats
Chapter One
1.0 Introduction
1.1 Background of the study
Metformin, which belongs to the biguanide class, is one of the most generally used oral hypoglycemic agents. It has been used for more than 50 years and was approved by the US Food and Drug Administration (FDA) in 1994 (American Diabetes Association, 2009). Currently, many clinical practice guidelines for patients with type 2 diabetes, including the American Diabetes Association (ADA), the European Association for the Study of Diabetes (EASD), and the Korean Diabetes Association (KDA), recommend that metformin treatment should begin at the time of diagnosis of diabetes with lifestyle modification in the absence of contraindications. Metformin is now the most widely used anti-diabetic drug, with almost all guidelines throughout the world recommending metformin as first-line treatment for patients with type 2 diabetes mellitus (T2DM). Metformin may also be used to treat other conditions involving insulin resistance, such as polycystic ovary syndrome (PCOS) (Boyleet al., 2010). Metformin has beneficial effects on carbohydrate metabolism, weight loss, and vascular protection but also has important side effects. For example, patients on long-term metformin therapy were found to be at risk of anaemia (Maidaet al., 2011). This may be due to a metformin related vitamin B12reduction. It is reported that, 30% of patients receiving long-term metformin treatment experienced malabsorption of vitamin B12,with a decrease in serum vitamin B12 concentration of 14% to30% (Burcelin, 2014).
Vitamin B12 is a vital nutrient for health. It plays an important role in the functioning of the brain and nervous system, and in the formation of red blood cells. In addition to anemia, vitamin B12deficiency may increase the severity of peripheral neuropathy inpatients with T2DM (Owenet al., 2000; Stephenne et al., 2011). Furthermore, because vitamin B12participates in the most important pathway of homocysteine (Hcy)metabolism, a reduction in vitamin B12 would increase plasma concentrations of Hcy, which is strongly linked to cardiovascular disease in patients with T2DM and PCOS (Saeediet al., 2008).Although some clinical studies have reported that metformin lowered vitamin B12 level, other studies have reported that it did not. To date, no consensus has been reached on whether metformin induces vitamin B12 reduction. It is therefore imperative to know the effect of metformin on the hematological parameters of experimental animal (Wistar Rats) so as to arrive at a conclusion if the vitamin B12 deficiency is as a result of Diabetes mellitus or due to metformin (anti-diabetic drug) (Leoneet al., 2014).
On the other hand, co-administration of metformin and amilodipine have been used in patients with type 2 diabetes with concomitant hypertension (type 2 diabetes-induced hypertension)(Wang et al., 2009).Amlodipine (as besylate, mesylate or maleate) is a long acting calcium channel blocker (dihydropyridine class)used as an anti-hypertensive and in the treatment of angina (Violletet al., 2012). Like other calcium channel blockers, amlodipine acts by relaxing the smooth muscle in the arterial wall, decreasing peripheral resistance and hence reducing blood pressure; in angina it increases blood flow to the heart muscle (Patade and Marita, 2014).
Amlodipine (an antihypertensive medication) have been found to be associated with a reduction in hemoglobin concentration with a long term exposure (Yamagduchi et al., 2005).The magnitude of such a change is generally small, but in certain instances it can be extreme enough to produce a clinically significant degree of anemia (Zankat et al., 2015). The mechanistic basis for antihypertensive medication-related changes in hemoglobin concentration include hemodilution, hemolytic anemia, and suppression of red blood cell production, as this occurs most commonly with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (Lakshmi et al., 2015). Researchers are suspecting that reduction in hemoglobin concentration in a patient who is receiving treatment for hypertension and does not have anobvious source of blood loss should account for potential antihypertensive therapy involvement (Bogachus and Turcotte, 2010).To find solution to the un-going suspicions and hypothesis.
It was therefore imperative to investigate the effect of co-administration of metformin and amlodipine on some hematological parameters in experimental animal (Wistar Rats).
1.2 Statement of problem
Drug-drug interactions are a major problem in health facilities the world over. The prevalence of interactions is estimated to be between 1- 22% (Lakshmi et al., 2015). Underlying risk factors for drug-drug interactions include polypharmacy and co-morbid conditions. High blood pressure in patients with diabetes presents a major health problem because of increased risk of polypharmacy. Polypharmacy leads to prescribing drugs that may have drug interactions. The interactions can lead to life threatening situations, hospitalization, increased burden to patients, hematotocixitiy (anaemia either haemolytic or vitamin B12 deficiency) as well as suppression of bone marrow activity from calcium blocker mechanism of antihypertensive drugs and adjusted quality of life. A considerable number of the drug-drug interactions can be avoided if health workers involved in patient care have the right information. Various hospitals and clinics serves patients from various regions that visit the facility for various ailments including diabetes and hypertension which are among the conditions on the rise, thus availability of data for the study is essential.
1.3 Justification
There are no local studies on the hematotoxicity of potential drug-drug interactions among patients receiving both hypoglycemic and antihypertensives drug and thus the need to carry out the study. Many hypothesis and theory have been postulated by researchers that long term usage of metformin have the ability to induce Vitamin B12 deficiency as well as some institutions having the complain that metformin drug despite it’s world-wide acceptability as anti-diabetic drug causes haemolytic anaemia. This led to the need to bridge the knowledge gap by carry out the study. Also, hypothesis have been postulated that long term usage of anti-hypertensive drugs causes a decrease in haemoglobin in which the mechanism is not known yet. This led to the need to bridge the knowledge gap by carry out the study.The findings of this study will create awareness to the clinicians and pharmacists on the need for a better dosage or a better drug so as to prevent hematotoxicity effect of drug-drug interactions in the case of diabetics with concomitant hypertension.
1.4 Aim
This study aims at investigating the combine effect of Metformin and Amilodipine on haematological experimental animal (Wistar Rats)
1.5 Research objectives
- To assess the MCV level of experimental animal and that of control group after combined administration with amilodipine and metformin.
- To investigate the MCH level of experimental animal and that of control group after combined administration with amilodipine and metformin.
- To determine the MCHC level of experimental animal and that of control group after combined administration with amilodipine and metformin.
1.6 Research hypothesis (Null)
- There is no significant difference in the level of MCV level after co-administration of amilodipine and metformin.
- There is no significant difference in the level of MCH level after co-administration of amilodipine and metformin.
- There is no significant difference in the level of MCHC level after co-administration of amilodipine and metformin.
1.7 Significance of research
Findings from this study will help policy makers to determine if long term exposure to Amilodipine and Metformin causes anaemia thus thus creating awareness of the drug usage to prevent hematoxicity (another form of complication to diabetic-hypertensive situation). Also the findings from the effect of Metformin and Amilodipine on experimental animal (Wistar Rat) will further generate need to examine the other complications that arise from the combined drug usage.
Chapter Five
5.0 Discussion
Metformin (1,1-dimethylbiguanide) is the most widely used drug to treat type 2 diabetes, and is one of only two oral anti-diabetic drugs on the World Health Organization (WHO) list of essential medicines (American Diabetes Association, 2009). Amlodipine is a long acting dihydropyridine calcium channel blocker, which is used in the treatment of angina to lower the BP. Co-administration of Metformin and Amlodipine have been discovered to lead to vitamin B12 deficiency. Alterations in the blood parameters are considered to be one of the most reliable indicators of toxic effects of drugs, chemicals, heavy metals, etc. (Lodia and Kansala, 2012).In this study, the haematotoxicity of co-administration of metformin and amlodipine were assessed in relation to untreated (control) Wistar Rat.
In the present study, Results of erythrogram showed decrease in haemoglobin (Hb), red blood cells (RBCs) count, packed cell volume (PCV) of Wistar rat treated with co-administration of metformin and Amlodipine (Figure 2 and Figure 3). The results obtained in this regards are consistent with the findings of (Takahashi-Iniguezet al., 2012). in exposed albino rat to 1mg/kg metformin-Amilodipine for 28 days. Expectedly there was a significant increase in mean corpuscular hemoglobin (MCH), mean corpuscular volume (MCV)along with no effect on the mean corpuscular hemoglobin concentration (MCHC)(Figure 4). These observations have been reported by (Parket al., 2009).In these studies the red cell dependent parameters were negatively correlated to metformin-amlodipine dose.
The differences observed in the various studies are attributed to difference in experimental model and design.
In has been suggested that metformin-amlodipine intoxication induced oxidative stress in rat plasma with effect on red blood cells as evidenced by increased lipid peroxidation and alters the antioxidant system in several tissue, which may result in oxidative damage by inhibition of erythrocyte Na+-K+ ATPase. Also other mechanisms have been proposed such as Vitamin B12 deficiency. The decrease in hematocrit values and haemoglobin is confirmation of the synergistic link between the two blood parameters in all vertebrates.
The current study indicates that oral exposure to metformin-Amlodipine significantly increase the total White Blood Cells count of Wistar Rat treated (Figure 5). Similar result was obtained by (Abdel-baky et al., 2013). The difference observed in previous study is attributed to difference in experimental model and design. Increase in white blood cell count might be due to intoxications and tissue necrosis due to the participation of Neutrophils and Monocytes in the process of phagocytosis as scavengers for wide variety of particulate material (El-Demerdash et al., 2004). Moreover, the increased Neutrophils to lymphocytes ratio are an indicator for a systemic inflammation. It was clearly demonstrated that oral exposure to metformin-Amlodipine increases the Neutrophils/Lymphocytes ratio which might be due to the oxidative stress outcomes of co-administration (Gosslau et al., 2014). Regarding to platelet count there was decrease in platelet count of metformin-amlodipine treated group compared to the control group (Figure 6). This was also recorded by Abdel-baky et al., 2013. For the explanation we will err on the evidences provided by earlier researchers that there is possibility of destruction of platelet during continuous administration of metformin-amlodipine by the fall in the number and increase in their cell size of individual platelets.
5.1 Conclusion
Taken together our findings indicate that the co-administration of Metformin and Amlodipine in Wistar Rats had a serious effect on Red cell parameters with little or no effect on the red cell indices. In view of the present study, it can be concluded that co-administration of metformin and amlodipine have adetrimental effect on the hematological parameters (red cell indices) which unraveled its anaemia induced effect.
5.2 Recommendation
- From the present study, co-administration of metformin and amilodipinehas the ability to induce anaemia after a long-term usage. Hence the need for more human study to be made on patient to study the effect of long-term usage of both drugs in patients with diabetics as well as hypertension.
- Further study should be carried out to investigate the effect of co-administration of metformin and amilodipine on the biochemical parameters in Wistar Rats so as to unvail its mechanism of action (haemolytic anaemia from Bilirubin increase).
- Further study should also be carried to investigate the effect of co-administration of metformin and amilodipine on serum erythropoietin levels in Wistar Rats.
- Further study should also be carried to investigate the effect of co-administration of metformin and amilodipine on serum Vitamin B12 levels in Wistar Rats since research indicate that’s the mechanism of action.
- The effect of co-administration of metformin and amilodipineon Wistar Rats have been investigated hence the need studies in other experimental model.


The Complete Material Will Be Sent to You in Just 2 Steps
Quick & Simple…
![]()
Make Payment (Through Transfer) of ₦5,000 to the Account Below
![]() | Acc No: 0811003731 |
| Samphina Academy | |
| Current Account |
Or CLICK HERE To Pay With Debit Card
| FOR STUDENTS OUTSIDE NIGERIA | |
| CLICK HERE To Pay With Card ($15) | |
| FOR GHANA STUDENTS (GHS 100) | |
![]() | MTN MoMo |
| 0553978005 | |
| Douglas Osabutey | |
![]()
Send the Following Details on WhatsApp ( 07062590260 ) After Payment
- Payment Details
- TOPIC: Sub-Chronic Effect Of Co-Administration Of Methformine And Amilodipine On Some Haematological Indices In Experimental Animal (Wistar Rats)
The Complete Material Will Be Sent To You On WhatsApp After Receiving Your Details
T & C Apply
Students Review
List of Related Works
Renal Protective Effect Of Ginger On Wistar Albino Rat Fed With Drinking Water Containing Nitrate
The Antioxidant Effect Of Selenium On Malathion Toxicity On The Brain Of Male Wistar Rat
Hypolipidemic Effect Of Tigernut (Cyperus Esculentus) On Albino Rat
The Effects Of Aluminum Chloride On The Lungs And Kidneys Of Rats On Wheat Diet
Effect Of Cannabis On Memory And Recall In Albino White Rats
The Effect Of Vegetable Oil Biodiesel On The Tissues Of An Albino-Rat (Rattus Novergicus)
A Morphometric Study Of The Teratogenic Effect Of Aqueous Wistar Rat
The Impact Of Bisphenol A On Liver Functions And Haematological Parameters In Albino Rats
Antidiabetic Efficacy Of (Vernonia Amygdaline) Bitter Leaf Plant Extracts On Diabetic Albino Rats
The Effect Of Cabbage Juice On Ethanol-Induced Liver Damage In Rats
Blood Glucose-Lowering Potentials Of Annona Muricata Leaf Extract In Alloxan-Induced Diabetic Rats
The Effect Of Terminalia Catappa On Hormone Assay Of An Adult Male Wistar Rat
Antihyperlipidemic And Antioxidant Effects Of Phaseolus Vulgaris Linn In Wistar Rats
The Behavioral Teratogenic Effect Of Cimetidine On The Offsprings Of Albino Rats
Effects Of Marijuana Smoking On Some Cardiac Enzymes In Albino Rats
Effect Of N-Hexane Extract Of Musa Paradisiaca Pulp On Aspirin-Induced Ulcer In Albino Rats
Antilipidemic Effect Of Water (H20) Extract Of Desmodium Velutinum Leaves On Albino Wistar Rats
Effect Of Alcohol Consumption On Some Hepatic Functions Of Albino Rats
Effect Of Euphorbia Hirta On The Gastrointestinal Tract Of Albino Rats
Wound Healing And Anti-Inflammatory Activities Of Ceiba Pentendra (L.) Gaertn In Wistar Rats
The Histology Of The Heart Using Animal Models (Adult Wistar Rats)
Hepatotoxicity Of The Ethanolic Extracts Of Enantia Chlorantha Root On Wistar Albino Rats
Cardio Protective Activities Of N-Hexane Extract Of Desmodium Velutinum Stem On Albino Wister Rat
Cardio Protective Activities Of N-Hexane Extract Of Desmodium Velutinum Stem On Albino Wistar Rat
Effects Of Phoenix Dactyliferaon Some Reproductive Organs And Hormonal Profiles Of Male Wistar Rats
The Effect Of Pterrocarpus Mildbreadii Seed On Plasma HLD Cholesyerol Of Albino Rat
The Effect Of Pterocarpus Mildbreadii Seed On Plasma HDL Cholesterol Of Albino Rat
The Effects Of Prunus Dulcis Meal On Hormones In Adult Female Rat
Somatic And Genetic Effects Of Low Sar 2.45 GHz Microwave Radiation On Wistar Rats
Histological Studies On The Effect Of Aspilia Africana On The Kidneys Of Albino Rats


